Quality of life after lung volume reduction surgery

Thoracic Surgery Clinics
Douglas E Wood

Abstract

The common physiologic and functional variables that quantify limitation in emphysema patients have been the most common outcomes measured after LVRS. Spirometric values and exercise capacity are merely surrogates, however, for their impact on symptoms and QOL in patients with severe emphysema. Because LVRS has been developed as a surgery to palliate disabling symptoms of emphysema, many studies now have included HRQOL outcomes along with the commonly measured physiologic and functional outcomes. Some studies have centered on the QOL as the primary outcome instead of physiologic variables. Many symptom scales and disease-specific and general instruments of HRQOL have been used for evaluating emphysema patients before and after LVRS. Case-control studies and randomized studies have shown a consistent improvement in symptoms related to emphysema and general QOL. These studies validate the use of LVRS as a palliative therapy for selected patients with emphysema. The NETT suggests that this benefit is applicable primarily to patients with an upper lobe-predominant pattern of emphysema or patients with low exercise capacity. Validation or refinement of these criteria depends on the continued contributions of the many investigators p...Continue Reading

References

Jan 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·J D CooperC L Roper
Nov 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·J D CooperS S Lefrak
Jul 27, 2000·The New England Journal of Medicine·D GeddesP Goldstraw
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·A F GelbN Zamel
Oct 13, 2001·The New England Journal of Medicine·UNKNOWN National Emphysema Treatment Trial Research GroupRobert Wise
Feb 15, 2002·The European Respiratory Journal·J HamacherE W Russi
Mar 26, 2003·Seminars in Thoracic and Cardiovascular Surgery·Roger D YusenKathy L Brown
Mar 27, 2003·The Journal of Thoracic and Cardiovascular Surgery·Anna Maria CicconeJoel D Cooper
May 22, 2003·The New England Journal of Medicine·Alfred FishmanUNKNOWN National Emphysema Treatment Trial Research Group
May 22, 2003·The New England Journal of Medicine·Scott D RamseyUNKNOWN National Emphysema Treatment Trial Research Group
Feb 4, 2009·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Kelby G Maher, Scot T Bateman

❮ Previous
Next ❯

Citations

Sep 15, 2009·International Journal of Chronic Obstructive Pulmonary Disease·David Anderson, William Macnee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Chest Surgery Clinics of North America
Douglas E Wood
Respiration; International Review of Thoracic Diseases
Konrad E BlochErich W Russi
European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
T GeiserH B Ris
© 2021 Meta ULC. All rights reserved